Farther Finance Advisors’s Context Therapeutics CNTX Stock Holding History

Farther Finance Advisors’s Portfolio CNTX Stock Details CNTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$831	Hold	1,500	–	–	﹤0.01%	5420
2026 Q1	$3.98K	Hold	1,500	–	–	﹤0.01%	4600
2025 Q4	$2.21K	Buy	+1,500	New	+$1.75K	﹤0.01%	4657

Other funds holding CNTX

FIA

FNY Investment Advisers New York $278M AUM 98.95% 1-Year Est. Return

Farther Finance Advisors's CNTX Position: Q2 2026 in Review

Farther Finance Advisors held its Context Therapeutics (CNTX) position steady in Q2 2026 at 1,500 shares worth $831. The position accounts for ﹤0.01% of the portfolio, ranked #5420.

Farther Finance Advisors first reported a position in CNTX in Q4 2025 and has held it in 3 quarters since. The position peaked at $3.98K in Q1 2026. 2 funds tracked by Wall St. Rank hold CNTX as of Q2 2026.

Farther Finance Advisors held 1,500 shares of Context Therapeutics worth $831 as of Q2 2026.
Farther Finance Advisors left its Context Therapeutics share count unchanged in Q2 2026.
Context Therapeutics made up ﹤0.01% of Farther Finance Advisors's portfolio in Q2 2026, its #5420 holding.
Farther Finance Advisors first reported a position in Context Therapeutics in Q4 2025 and has held it in 3 quarters since.
Farther Finance Advisors's Context Therapeutics position peaked at $3.98K in Q1 2026.
2 funds tracked by Wall St. Rank held Context Therapeutics as of Q2 2026.

Based on Farther Finance Advisors's 13F filing for Q2 2026, filed 17 Jul 2026.